Patent Assignment
Reel/Frame 067040/0637
Security Interest
Recorded: 2024-04-08
Pages: 13
Assignor
ZEVRA THERAPEUTICS, INC.
Executed: 2024-04-05
Assignee
ALTER DOMUS (US) LLC
225 W WASHINGTON STREET, 9TH FLOOR, CHICAGO, ILLINOIS, 60606
Covered Properties
(89)
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Uses Thereof
Application:
14/534,852 →
Publication:
US 2015/0065536
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Uses Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Uses Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Uses Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Uses Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Use Thereof
Phenylethanoic Acid, Phenylpropanoic Acid and Phenylpropenoic Acid Conjugates and Prodrugs of Hydrocodone, Method of Making and Use Thereof
Phenylethanoic Acid, Phenylpropanoic Acid and Phenylpropenoic Acid Conjugates and Prodrugs of Hydrocodone, Methods of Making and Use Thereof
Application:
13/378,857 →
Publication:
US 2012/0142720
Phenylethanoic Acid, Phenylpropanoic Acid and Phenylpropenoic Acid Conjugates and Prodrugs of Hydrocodone, Method of Making and Use Thereof
Amino Acid Conjugates of Quetiapine, Process for Making and Using the Same
Application:
12/976,546 →
Publication:
US 2011/0183963
Fatty Acid Conjugates of Quetiapine, Process for Making and Using the Same
Application:
13/043,764 →
Publication:
US 2011/0223207
Amino Acid Conjugates of Quetiapine, Process for Making and Using the Same
Fatty Acid Conjugates of Quetiapine, Process for Making and Using the Same
Fatty Acid Conjugates of Quetiapine, Process for Making and Using the Same
Application:
13/770,462 →
Publication:
US 2013/0158007
Amino Acid Conjugates of Quetiapine, Process for Making and Using the Same
Fatty Acid Conjugates of Quetiapine, Process for Making and Using the Same
Fatty Acid Conjugates of Quetiapine, Process for Making and Using the Same
Application:
15/340,533 →
Publication:
US 2017/0042906
Amino Acid Conjugates of Quetiapine, Process for Making and Using the Same
Application:
15/431,054 →
Publication:
US 2017/0209586
Fatty Acid Conjugates of Quetiapine, Process for Making and Using the Same
Fatty Acid Conjugates of Quetiapine, Process for Making and Using the Same
Amino Acid Conjugates of Quetiapine, Process for Making and Using the Same
Amino Acid Conjugates of Quetiapine, Process for Making and Using the Same
Application:
15/595,380 →
Publication:
US 2017/0246308
Methylphenidate-Oxoacid Conjugates, Processes of Making and Using the Same
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application:
62/432,675 →
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application:
16/244,460 →
Publication:
US 2019/0142815
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydromorphone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydromorphone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydromorphone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydromorphone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydromorphone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydromorphone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Oxycodone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Oxycodone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Oxycodone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Oxymorphone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Oxymorphone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Oxymorphone, Prodrugs, Methods of Making and Use Thereof
Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Oxymorphone, Prodrugs, Methods of Making and Use Thereof
Immediate-Release Abuse Deterrent Compositions or Medicaments for Treating Pain, Add, Adhd and Other Syndromes or Disorders
Application:
16/341,636 →
Publication:
US 2020/0038383
Pharmaceutically Acceptable Salts and Polymorphic Forms of Hydrocodone Benzoic Acid Enol Ester and Processes for Making Same
Pharmaceutically Acceptable Salts and Polymorphic Forms of Hydrocodone Benzoic Acid Enol Ester and Processes for Making Same
Pharmaceutically Acceptable Salts and Polymorphic Forms of Hydrocodone Benzoic Acid Enol Ester and Processes for Making Same
Application:
16/352,125 →
Publication:
US 2019/0256522
Pharmaceutically Acceptable Salts and Polymorphic Forms of Hydrocodone Benzoic Acid Enol Ester and Processes for Making Same
Levorphanol Prodrugs and Processes for Making and Using Them
Application:
62/485,888 →
Levorphanol Prodrugs and Processes for Making and Using Them
Levorphanol Prodrugs and Processes for Making and Using Them
Levorphanol Prodrugs and Processes for Making and Using Them
Dextrorphan Prodrugs and Processes for Making and Using Them
Dextrorphan Prodrugs and Processes for Making and Using Them
Ketamine Compounds and Processes for Making and Using Them
Ketamine Compounds and Processes for Making and Using Them
Application:
18/355,983 →
Publication:
US 2023/0355550
Therapeutic Formulation for Reduced Drug Side Effects
Compositions for Reduction of Side Effects
Compositions for Reduction of Side Effects
Application:
15/339,453 →
Publication:
US 2017/0105983
Therapeutic Formulation for Reduced Drug Side Effects
Compositions for Reduction of Side Effects
Application:
61/609,590 →
Therapeutic Formulation for Reduced Drug Side Effects
Application:
61/327,486 →
Therapeutic Formulation for Reduced Drug Side Effects
Application:
61/369,338 →
Therapeutic Formulation
Application:
61/550,119 →
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Compositions Comprising Methlphenidate-Prodrugs, Processes of Making and Using the Same
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application:
17/240,181 →
Publication:
US 2021/0253552
D-Amphetamine Compounds, Compositions, and Processes for Making and Using the Same
D-Amphetamine Compounds, Compositions, and Processes for Making and Using the Same
D-Amphetamine Compounds, Compositions, and Processes for Making and Using the Same
D-Amphetamine Compounds, Compositions, and Processes for Making and Using the Same
Application:
18/432,949 →
Publication:
US 2024/0199551
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application:
17/798,491 →
Publication:
US 2023/0117289
Gamma-Hydroxybutyrate Delivering Compounds and Processes for Making and Using Them
Application:
18/303,191 →
Publication:
US 2023/0338543
Gamma-Hydroxybutyrate Delivering Compounds and Processes for Making and Using Them
Application:
18/303,200 →
Publication:
US 2023/0382851
Gamma-Hydroxybutyrate Delivering Compounds and Processes for Making and Using Them
Application:
18/303,220 →
Publication:
US 2023/0382881
Gamma-Hydroxybutyrate Delivering Compounds and Processes for Making and Using Them
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 13, 2010
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 024977/0609 →
Assignment of Assignor's Interest
Sep 13, 2010
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 024977/0440 →
Assignment of Assignor's Interest
Feb 23, 2012
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 027753/0751 →
Assignment of Assignor's Interest
Feb 23, 2012
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 027753/0643 →
Assignment of Assignor's Interest
May 31, 2013
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 030523/0380 →
Assignment of Assignor's Interest
May 31, 2013
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 030523/0208 →
Assignment of Assignor's Interest
May 31, 2013
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 030523/0296 →
Security Interest
Jun 3, 2014
From: KEMPHARM, INC.
To: DEERFIELD PRIVATE DESIGN FUND III, L.P.
Reel/Frame 033079/0927 →
Assignment of Assignor's Interest
Oct 21, 2014
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL
To: KEMPHARM, INC.
Reel/Frame 033996/0368 →
Assignment of Assignor's Interest
Jan 28, 2015
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 034828/0656 →
Assignment of Assignor's Interest
Jan 28, 2015
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 034828/0355 →
Assignment of Assignor's Interest
Jan 19, 2016
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 037522/0397 →
Assignment of Assignor's Interest
Jan 20, 2016
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 037537/0001 →
Assignment of Assignor's Interest
Oct 18, 2016
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 040048/0735 →
Assignment of Assignor's Interest
Feb 14, 2018
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 044933/0608 →
Assignment of Assignor's Interest
Feb 14, 2018
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 044933/0597 →
Assignment of Assignor's Interest
Mar 16, 2018
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 045254/0754 →
Assignment of Assignor's Interest
Mar 16, 2018
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 045253/0497 →
Assignment of Assignor's Interest
Mar 19, 2018
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 045274/0436 →
Corrective Assignment to Correct the Assignee's Address Previously Recorded at Reel: 037522 Frame: 0397. Assignor(S) Hereby Confirms the Assignment.
Sep 5, 2018
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 047019/0495 →
Corrective Assignment to Correct the Assignee's Address Previously Recorded at Reel: 037537 Frame: 0001. Assignor(S) Hereby Confirms the Assignment.
Sep 5, 2018
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 047022/0437 →
Assignment of Assignor's Interest
Feb 20, 2019
From: MICKLE, TRAVIS; GUENTHER, SVEN; MICKLE, CHRISTAL; CHI, GUOCHEN
To: KEMPHARM, INC.,
Reel/Frame 048387/0148 →
Security Interest
Feb 28, 2020
From: KEMPHARM, INC.
To: DEERFIELD PRIVATE DESIGN FUND III, L.P.
Reel/Frame 051968/0714 →
Release of Security Interest
Jul 9, 2021
From: DEERFIELD PRIVATE DESIGN FUND III, L.P.
To: KEMPHARM, INC.
Reel/Frame 056803/0133 →
Change of Name
Feb 23, 2024
From: KEMPHARM, INC.
To: ZEVRA THERAPEUTICS, INC.
Reel/Frame 066664/0108 →